199 related articles for article (PubMed ID: 34510716)
1. A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer.
van den Berg I; Smid M; Coebergh van den Braak RRJ; van de Wiel MA; van Deurzen CHM; de Weerd V; Martens JWM; IJzermans JNM; Wilting SM
Mol Oncol; 2021 Dec; 15(12):3348-3362. PubMed ID: 34510716
[TBL] [Abstract][Full Text] [Related]
2. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
Li X; Larsson P; Ljuslinder I; Ling A; Löfgren-Burström A; Zingmark C; Edin S; Palmqvist R
Pathol Res Pract; 2021 Apr; 220():153379. PubMed ID: 33721619
[TBL] [Abstract][Full Text] [Related]
3. [Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)].
Wielandt AM; Villarroel C; Hurtado C; Simian D; Zamorano D; Martínez M; Castro M; Vial MT; Kronberg U; López-Kostner F
Rev Med Chil; 2017 Apr; 145(4):419-430. PubMed ID: 28748988
[TBL] [Abstract][Full Text] [Related]
4. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.
Naumov VA; Generozov EV; Zaharjevskaya NB; Matushkina DS; Larin AK; Chernyshov SV; Alekseev MV; Shelygin YA; Govorun VM
Epigenetics; 2013 Sep; 8(9):921-34. PubMed ID: 23867710
[TBL] [Abstract][Full Text] [Related]
5. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
6. A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues.
de Back TR; Wu T; Schafrat PJ; Ten Hoorn S; Tan M; He L; van Hooff SR; Koster J; Nijman LE; Vink GR; Beumer IJ; Elbers CC; Lenos KJ; Sommeijer DW; Wang X; Vermeulen L
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38782602
[TBL] [Abstract][Full Text] [Related]
7. Consensus molecular subtype classification of colorectal adenomas.
Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer.
Yu H; Wang X; Bai L; Tang G; Carter KT; Cui J; Huang P; Liang L; Ding Y; Cai M; Huang M; Liu H; Cao G; Gallinger S; Pai RK; Buchanan DD; Win AK; Newcomb PA; Wang J; Grady WM; Luo Y
J Natl Cancer Inst; 2023 Jan; 115(1):52-61. PubMed ID: 36171645
[TBL] [Abstract][Full Text] [Related]
9. Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.
Muthamilselvan S; Raghavendran A; Palaniappan A
PLoS One; 2022; 17(2):e0249151. PubMed ID: 35202405
[TBL] [Abstract][Full Text] [Related]
10. A novel discriminating colorectal cancer model for differentiating normal and tumor tissues.
Sun X; Tian Y; Zheng Q; Zheng R; Lin A; Chen T; Zhu Y; Lai M
Epigenomics; 2018 Nov; 10(11):1463-1475. PubMed ID: 30324808
[TBL] [Abstract][Full Text] [Related]
11. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V
Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496
[TBL] [Abstract][Full Text] [Related]
12. Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype.
Gebhard C; Mulet-Lazaro R; Glatz D; Schwarzfischer-Pfeilschifter L; Schirmacher P; Gaedcke J; Weichert W; Reuschel E; Dietmaier W; Rehli M
Int J Cancer; 2022 Feb; 150(4):617-625. PubMed ID: 34591983
[TBL] [Abstract][Full Text] [Related]
13. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Heiss JA; Brenner H
Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
[TBL] [Abstract][Full Text] [Related]
14. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
15. A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival.
Jia M; Zhang Y; Jansen L; Walter V; Edelmann D; Gündert M; Tagscherer KE; Roth W; Bewerunge-Hudler M; Herpel E; Kloor M; Ulrich A; Burwinkel B; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
Clin Epigenetics; 2019 Jul; 11(1):109. PubMed ID: 31340858
[TBL] [Abstract][Full Text] [Related]
16. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.
Draht MX; Smits KM; Tournier B; Jooste V; Chapusot C; Carvalho B; Cleven AH; Derks S; Wouters KA; Belt EJ; Stockmann HB; Bril H; Weijenberg MP; van den Brandt PA; de Bruïne AP; Herman JG; Meijer GA; Piard F; Melotte V; van Engeland M
Mol Oncol; 2014 May; 8(3):679-88. PubMed ID: 24560444
[TBL] [Abstract][Full Text] [Related]
17. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
[TBL] [Abstract][Full Text] [Related]
18. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E
Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling.
Endo Y; Fujimoto M; Ito N; Takahashi Y; Kitago M; Gotoh M; Hiraoka N; Yoshida T; Kitagawa Y; Kanai Y; Arai E
J Cancer Res Clin Oncol; 2021 May; 147(5):1341-1354. PubMed ID: 33635431
[TBL] [Abstract][Full Text] [Related]
20. Identification of two methylated fragments of an SDC2 CpG island using a sliding window technique for early detection of colorectal cancer.
Li R; Qu B; Wan K; Lu C; Li T; Zhou F; Lin J
FEBS Open Bio; 2021 Jul; 11(7):1941-1952. PubMed ID: 33955718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
